Rivacor
Device Cardiology/Vascular Diseases
PDI 04035479156794
General payments
$1,453,669
Research payments
$774,549
Through program year 2021, $1,453,669 in general payments and $774,549 in research payments were reported against Rivacor (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $1,453,669 | 12,512 |
| 2021 | Research | $774,549 | 6,163 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 69 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
12,512 general · 6,163 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.